サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291627

膵臓がんの治療および診断市場：タイプ別（診断、治療）、用途別（病院、診療所、その他）、地域別2023-2028

Pancreatic Cancer Therapeutics and Diagnostics Market by Type (Diagnostics, Treatment), Application (Hospitals, Clinics, and Others), and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
膵臓がんの治療および診断市場：タイプ別（診断、治療）、用途別（病院、診療所、その他）、地域別2023-2028
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界の膵臓がんの治療および診断市場規模は、2022年に39億6,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.46%の成長率（CAGR）を示し、2028年までに60億8,000万米ドルに達すると予測しています。ヘルスケア産業の急成長、膵臓がんの有病率の上昇、膵臓がん細胞を死滅させる化学療法の需要の高まりが、市場を牽引する重要な要因の一部となっています。

膵臓がんの治療および診断は、膵臓がんを診断し、治療を行うために使用される医療処置です。これらの治療・診断には、超音波検査、コンピュータ断層撮影（CT）検査、磁気共鳴画像法（MRI）検査、陽電子放射断層撮影（PET）検査が含まれます。超音波検査は、超音波装置を用いて腹部から膵臓を撮影する内視鏡的超音波検査（EUS）により行われます。膵臓の細胞が制御不能に増殖しているため、腫瘍の位置をモニターするのに役立ちます。また、顕微鏡で検査するために小さな組織を採取する生検の実施もサポートします。また、全血球計算（CBC）、胆道閉塞のための肝酵素検査、空腹時血糖値や糖化ヘモグロビン（HbA1C）検査などの検査室での検査もサポートします。その結果、膵臓がんの治療および診断は、世界中の病院や専門センターで使用されています。

膵臓がんの治療および診断の市場動向：

現在、高齢者人口の増加や喫煙習慣の増加により、膵臓がんの有病率が上昇していることが、市場の成長を支える重要な要因の1つとなっています。また、分子生物学、医薬品、診断技術の開発が世界的に進んでいます。このことは、ヘルスケア産業の繁栄とともに、現在、市場の成長を後押ししています。また、膵臓がん細胞の増殖や分裂を抑制して死滅させる化学療法の需要が高まっていることも、市場にプラスの影響を与えています。さらに、いくつかの国の政府機関は、膵臓がんの臨床試験や化学療法と組み合わせたデオキシリボ核酸（DNA）修復阻害剤への投資を積極的に行っています。また、臨床段階にある薬剤を承認することで、膵臓がん治療薬や診断薬の成長を促進することにも力を入れています。これとは別に、業界で活動する主要企業は、食道・胃食道接合部および膵臓がんの治療のために、抗腫瘍免疫応答を促進するヒト化モノクローナル抗体を導入しています。また、BRCA1およびBRCA2バリアントの判定やゲノム不安定性の評価により膵臓がんを検出するキットベースの検査を開発・導入しており、今後数年間の市場成長に寄与すると予測されます。

本レポートで回答した主な質問

  • 世界の膵臓がんの治療および診断市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界の膵臓がんの治療および診断市場における市場促進要因、抑制要因、機会は何か？
  • 主要な地域市場とは？
  • 最も魅力的な膵臓がんの治療および診断市場はどの国か？
  • 市場内訳のタイプ別内訳は？
  • 膵臓がんの治療および診断市場において最も魅力的なタイプは何か？
  • 用途に基づく市場の内訳は？
  • 膵臓がんの治療および診断市場で最も魅力的な用途はどれか？
  • 世界の膵臓がんの治療および診断市場の競争構造は？
  • 世界の膵臓がんの治療および診断市場における主要なプレーヤー/企業はどこか？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 膵臓がんの治療および診断の世界市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 タイプ別市場内訳

  • 診断
    • 市場動向
    • 主要セグメント
      • 画像診断
      • 生検
      • 内視鏡用超音波
      • その他
    • 市場予測
  • 治療
    • 市場動向
    • 主要セグメント
      • 標的治療
      • 化学療法
      • 手術療法
      • その他
    • 市場予測

第7章 用途別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 診療所
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第9章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AstraZeneca plc
    • F. Hoffmann-La Roche Ltd.
    • Immunovia AB
    • Novartis AG
    • Pfizer Inc.

本レポートに記載されている企業名は一部であり、全企業名は本レポートに記載されています。

図表

List of Figures

  • Figure 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: North America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: North America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: United States: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: United States: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: China: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: China: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: India: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: India: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: France: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: France: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 65: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
  • Figure 67: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
  • Figure 68: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Competitive Structure
  • Table 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Players
目次
Product Code: SR112023A7538

Market Overview:

The global pancreatic cancer therapeutics and diagnostics market size reached US$ 3.96 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.08 Billion by 2028, exhibiting a growth rate (CAGR) of 7.46% during 2023-2028. The burgeoning healthcare industry, rising prevalence of pancreatic cancer, and the escalating demand for chemotherapy to kill pancreatic cancer cells represent some of the key factors driving the market.

Pancreatic cancer therapeutics and diagnostics are medical procedures used to diagnose pancreatic cancer and provide treatment. These therapeutics and diagnostics comprise ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. They rely on an endoscopic ultrasound (EUS) that uses an ultrasound device to produce images of the pancreas from inside the abdomen. They help in monitoring the location of the tumor due to an uncontrollable growth of cells in the pancreas. They assist in performing a biopsy to remove a small sample of tissue for examination under a microscope. They also aid in laboratory investigations, such as a complete blood count (CBC), liver enzyme tests for biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests. As a result, pancreatic cancer therapeutics and diagnostics find applications in hospitals and specialty centers across the globe.

Pancreatic Cancer Therapeutics and Diagnostics Market Trends:

At present, the rising prevalence of pancreatic cancer due to the increasing geriatric population and excessive smoking habits among the masses represents one of the key factors supporting the growth of the market. Besides this, there is an increase in the development of molecular biology, drugs, and diagnostic technology around the world. This, along with the thriving healthcare industry, is currently propelling the growth of the market. In addition, the escalating demand for chemotherapy to kill pancreatic cancer cells by preventing them from growing and dividing is positively influencing the market. Moreover, governing agencies of several countries are extensively investing in pancreatic cancer clinical trial testing and deoxyribonucleic acid (DNA) repair inhibitors combined with chemotherapy. They are also focusing on enhancing the growth of pancreatic cancer therapeutics and diagnostics by approving drugs in the clinical phase. Apart from this, key players operating in the industry are introducing a humanized monoclonal antibody that promotes the anti-tumor immune response for treating esophageal and gastroesophageal junction and pancreatic cancer. They are also developing and introducing kit-based testing to detect pancreatic cancer by determining BRCA1 and BRCA2 variants and assessing genomic instability, which is projected to contribute to the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pancreatic cancer therapeutics and diagnostics market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type and application.

Type Insights:

  • Diagnostics
    • Imaging
    • Biopsy
    • Endoscopic Ultrasound
    • Others
  • Treatment
    • Targeted Therapies
    • Chemotherapy
    • Surgery
    • Others

The report has provided a detailed breakup and analysis of the pancreatic cancer therapeutics and diagnostics market based on the type. This includes diagnostics (imaging, biopsy, endoscopic ultrasound, and others) and treatment (targeted therapies, chemotherapy, surgery, and others). According to the report, treatment accounted for the largest market share.

Application Insights:

  • Hospitals
  • Clinics
  • Others

A detailed breakup and analysis of the pancreatic cancer therapeutics and diagnostics market based on application has also been provided in the report. This includes hospitals, clinics, and others. According to the report, hospitals represented the leading segment.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pancreatic cancer therapeutics and diagnostics. Some of the factors driving the North America pancreatic cancer therapeutics and diagnostics market included advancements in diagnostic technologies, emerging therapies and treatment options, increasing healthcare expenditure, and government initiatives and funding.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global pancreatic cancer therapeutics and diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies include AstraZeneca plc, F. Hoffmann-La Roche Ltd., Immunovia AB, Novartis AG, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global pancreatic cancer therapeutics and diagnostics market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global pancreatic cancer therapeutics and diagnostics market?
  • What are the key regional markets?
  • Which countries represent the most attractive pancreatic cancer therapeutics and diagnostics markets?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the pancreatic cancer therapeutics and diagnostics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the pancreatic cancer therapeutics and diagnostics market?
  • What is the competitive structure of the global pancreatic cancer therapeutics and diagnostics market?
  • Who are the key players/companies in the global pancreatic cancer therapeutics and diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pancreatic Cancer Therapeutics and Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Imaging
      • 6.1.2.2 Biopsy
      • 6.1.2.3 Endoscopic Ultrasound
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Treatment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Targeted Therapies
      • 6.2.2.2 Chemotherapy
      • 6.2.2.3 Surgery
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AstraZeneca plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 F. Hoffmann-La Roche Ltd.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Immunovia AB
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Novartis AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Pfizer Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.